Department of Gastroenterology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, 160012, India.
BMC Gastroenterol. 2023 Feb 23;23(1):46. doi: 10.1186/s12876-023-02682-x.
Gastrointestinal strictures impact clinical presentation in abdominal tuberculosis and are associated with significant morbidity.
To conduct a systematic review of the prevalence of stricturing disease in abdominal and gastrointestinal tuberculosis and response to antitubercular therapy (ATT).
We searched Pubmed and Embase on 13th January 2022, for papers reporting on the frequency and outcomes of stricturing gastrointestinal tuberculosis. The data were extracted, and pooled prevalence of stricturing disease was estimated in abdominal tuberculosis and gastrointestinal (intestinal) tuberculosis. The pooled clinical response and stricture resolution (endoscopic or radiologic) rates were also estimated. Publication bias was assessed using the Funnel plot and Egger test. The risk of bias assessment was done using a modified Newcastle Ottawa Scale.
Thirty-three studies reporting about 1969 patients were included. The pooled prevalence of intestinal strictures in abdominal tuberculosis and gastrointestinal TB was 0.12 (95%CI 0.07-0.20, I = 89%) and 0.27 (95% CI 0.21-0.33, I = 85%), respectively. The pooled clinical response of stricturing gastrointestinal tuberculosis to antitubercular therapy was 0.77 (95%CI 0.65-0.86, I = 74%). The pooled stricture response rate (endoscopic or radiological) was 0.66 (95%CI 0.40-0.85, I = 91%). The pooled rate of need for surgical intervention was 0.21 (95%CI 0.13-0.32, I = 70%), while endoscopic dilatation was 0.14 (95%CI 0.09-0.21, I = 0%).
Stricturing gastrointestinal tuberculosis occurs in around a quarter of patients with gastrointestinal tuberculosis, and around two-thirds of patients have a clinical response with antitubercular therapy. A subset of patients may need endoscopic or surgical intervention. The estimates for the pooled prevalence of stricturing disease and response to ATT had significant heterogeneity.
胃肠道狭窄会影响腹腔结核的临床表现,并导致显著的发病率。
系统评价腹腔和胃肠道结核中狭窄性疾病的患病率以及抗结核治疗(ATT)的反应。
我们于 2022 年 1 月 13 日在 Pubmed 和 Embase 上检索了报告胃肠道结核狭窄频率和结局的论文。提取数据,并估计腹腔结核和胃肠道(肠道)结核中狭窄性疾病的总患病率。还估计了总临床反应和狭窄缓解(内镜或影像学)率。使用漏斗图和 Egger 检验评估发表偏倚。使用改良的 Newcastle-Ottawa 量表进行偏倚风险评估。
纳入了 33 项研究,共报告了 1969 例患者。腹腔结核和胃肠道结核中肠狭窄的总患病率分别为 0.12(95%CI 0.07-0.20,I=89%)和 0.27(95%CI 0.21-0.33,I=85%)。抗结核治疗对狭窄性胃肠道结核的总临床反应率为 0.77(95%CI 0.65-0.86,I=74%)。内镜或影像学狭窄缓解率为 0.66(95%CI 0.40-0.85,I=91%)。需要手术干预的总发生率为 0.21(95%CI 0.13-0.32,I=70%),而内镜扩张率为 0.14(95%CI 0.09-0.21,I=0%)。
胃肠道结核中约有四分之一的患者存在狭窄性疾病,约三分之二的患者对抗结核治疗有临床反应。部分患者可能需要内镜或手术干预。估计的狭窄性疾病总患病率和 ATT 反应的汇总数据存在显著异质性。